SJÖGREN´S SYNDROME
Clinical trials for SJÖGREN´S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJÖGREN´S SYNDROME trials appear
Sign up with your email to follow new studies for SJÖGREN´S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major drug trial tests Long-Term safety for autoimmune disease
Disease control Recruiting nowThis study aims to check the long-term safety of an experimental drug called dazodalibep for people with Sjögren's syndrome, an autoimmune disease. It's open to 844 participants who have already completed a previous 48-week trial with the same drug. The main goal is to monitor fo…
Matched conditions: SJÖGREN´S SYNDROME
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Last-Hope drug access opens for rare immune diseases
Disease control AVAILABLEThis is a special access program, not a traditional clinical trial. It provides the experimental drug ianalumab (VAY736) to patients with serious immune conditions like Primary Immune Thrombocytopenia (ITP) and Sjögren's Syndrome. The program is for patients who have no other tre…
Matched conditions: SJÖGREN´S SYNDROME
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New eye drop trial targets debilitating dryness in autoimmune disease
Symptom relief Recruiting nowThis study is testing a new eye drop called rhPRG4 to see if it is safe and effective for treating dry eye disease in people with Sjögren's syndrome. It will involve about 80 adults in Australia who will use the eye drop or a placebo for 28 days. The main goal is to see if the tr…
Matched conditions: SJÖGREN´S SYNDROME
Phase: PHASE2 • Sponsor: Lubris Bio Pty Ltd • Aim: Symptom relief
Last updated Mar 31, 2026 12:10 UTC